182.77
Insmed Inc 주식(INSM)의 최신 뉴스
3,909 Shares in Insmed, Inc. $INSM Purchased by Corton Capital Inc. - MarketBeat
Why Insmed Incorporated is moving todayWeekly Stock Recap & Weekly Breakout Watchlists - newser.com
What dividend safety score for Insmed Incorporated stockTake Profit & Risk Adjusted Swing Trade Ideas - newser.com
Will Insmed Incorporated stock benefit from automationTrend Reversal & Stepwise Swing Trade Plans - newser.com
Trend analysis for Insmed Incorporated this week2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
Can Insmed Incorporated stock deliver surprise earnings beatPortfolio Risk Summary & Fast Moving Trade Plans - newser.com
Assetmark Inc. Acquires 5,892 Shares of Insmed, Inc. $INSM - MarketBeat
Nisa Investment Advisors LLC Sells 1,556 Shares of Insmed, Inc. $INSM - MarketBeat
How Insmed Incorporated (IM8N) stock compares with tech leadersQuarterly Earnings Summary & Reliable Price Breakout Signals - newser.com
What machine learning models say about Insmed Incorporated2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
What indicators show strength in Insmed Incorporated2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Insmed Incorporated (INSM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Building trade automation scripts for Insmed IncorporatedBuy Signal & Technical Pattern Based Signals - newser.com
Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3 - Yahoo Finance
Insmed discovers new cathepsin C inhibitors - BioWorld MedTech
Is Insmed Incorporated (IM8N) stock a buy before new product rollout2025 Market Outlook & Weekly High Momentum Picks - newser.com
Historical volatility pattern of Insmed Incorporated visualized2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com
How Insmed Incorporated stock reacts to Fed rate cutsGap Down & Daily Profit Maximizing Tips - newser.com
Insmed Incorporated stock volume spike explainedJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
Earnings Beat: Insmed Incorporated (NASDAQ:INSM) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
Insmed, Inc. $INSM Position Reduced by Moody Aldrich Partners LLC - MarketBeat
Envestnet Asset Management Inc. Acquires 40,520 Shares of Insmed, Inc. $INSM - MarketBeat
Teacher Retirement System of Texas Has $4.93 Million Stake in Insmed, Inc. $INSM - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Q3 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Maintains Insmed (INSM) Overweight Recommendation - Nasdaq
Insmed Inc (INSM) Stock Price, Trades & News - GuruFocus
Insmed (NASDAQ:INSM) Posts Earnings Results, Misses Estimates By $0.40 EPS - MarketBeat
Wells Fargo Raises Price Target for INSM to $217, Maintains Over - GuruFocus
Goldman Sachs Maintains Insmed (INSM) Buy Recommendation - Nasdaq
Wells Fargo Raises Price Target for INSM to $217, Maintains Overweight Rating | INSM Stock News - GuruFocus
Insmed (NASDAQ:INSM) Hits New 12-Month HighTime to Buy? - MarketBeat
Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake - sharewise.com
Goldman Sachs Boosts Insmed (INSM) Price Target to $225 | INSM Stock News - GuruFocus
INSM: UBS Maintains 'Buy', Raises Price Target to $223 | INSM St - GuruFocus
Insmed Shares Likely to Gain From Brinsupri Sales, Untapped Pipeline, UBS Says - MarketScreener
Insmed stock surges as UBS raises price target on Brinsupri launch success - Investing.com Canada
Insmed (INSM) Sees Price Target Raised by RBC Capital to $215 | - GuruFocus
Insmed (INSM) Hits All-Time High as Firm Posts Highly Optimistic Outlook - Insider Monkey
Insmed Q3 2025 slides reveal strong BRINSUPRI debut, ARIKAYCE growth accelerates - Investing.com Australia
Insmed stock hits 52-week high at 170.3 USD By Investing.com - Investing.com Australia
RBC Raises Price Target on Insmed to $215 From $139, Keeps Outperform Rating - MarketScreener
Cantor Fitzgerald Comments on Insmed FY2025 Earnings - MarketBeat
UBS Adjusts Insmed Price Target to $223 From $194, Maintains Buy Rating - MarketScreener
Truist Raises Price Target on Insmed to $214 From $139, Keeps Buy Rating - MarketScreener
Insmed: Q3 Earnings Snapshot - Stamford Advocate
Emerald Mutual Fund Advisers Trust Sells 328,407 Shares of Insmed, Inc. $INSM - MarketBeat
Emerald Advisers LLC Decreases Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Reaches Analyst Target Price - Nasdaq
Insmed, Inc. $INSM Shares Sold by Jennison Associates LLC - MarketBeat
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
자본화:
|
볼륨(24시간):